garenoxacin has been researched along with Recrudescence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, J; Higa, F; Hiramatsu, K; Kadota, J; Kohno, S; Tateyama, M; Tokimatsu, I; Yamamoto, Y; Yanagihara, K | 1 |
| Chinushi, M; Nakamura, Y; Ochiai, S; Sato, A; Tagawa, M | 1 |
1 trial(s) available for garenoxacin and Recrudescence
| Article | Year |
|---|---|
Early switch therapy from intravenous sulbactam/ampicillin to oral garenoxacin in patients with community-acquired pneumonia: a multicenter, randomized study in Japan.
Topics: Administration, Oral; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Community-Acquired Infections; Female; Fluoroquinolones; Humans; Injections, Intravenous; Japan; Male; Middle Aged; Pneumonia, Bacterial; Recurrence; Sulbactam; Treatment Outcome | 2013 |
1 other study(ies) available for garenoxacin and Recrudescence
| Article | Year |
|---|---|
Secondly ECG recordings in the emergency room revealed Garenoxacin-induced abnormal QT interval prolongation in a patient with multiple syncopal attacks.
Topics: Adrenergic Agonists; Adrenergic beta-1 Receptor Antagonists; Aged; Anti-Bacterial Agents; Electrocardiography; Emergency Service, Hospital; Epinephrine; ERG1 Potassium Channel; Exercise Test; Female; Fluoroquinolones; Genetic Predisposition to Disease; Heart Rate; Humans; Long QT Syndrome; Metoprolol; Mutation; Phenotype; Predictive Value of Tests; Recurrence; Risk Factors; Syncope | 2016 |